Home » Authors » Jim Shrine

Jim Shrine

Articles

ARTICLES

NeurogesX Presents Positive Data From Trial Of Pain Patch

Nov. 1, 2011

No Abstract

NewCo News: Aileron Raises $7M For Work On Peptide Technology Platform

Nov. 1, 2011

No Abstract

KineMed Applying Translation Technologies In Deal With Bayer

Nov. 1, 2011

No Abstract

Renovis Cuts Staff As Focus Moves To Preclinical Programs

Nov. 1, 2011

No Abstract

Santhera Starts Phase III Trial In Friedreich's Ataxia Patients

Oct. 1, 2007

Santhera Starts Phase III Trial In Friedreich's Ataxia Patients

Oct. 1, 2007

NPS, Nycomed Enter Potential $185M Deal Covering Gattex

Sep. 27, 2007

NPS, Nycomed Enter Potential $185M Deal Covering Gattex

Sep. 27, 2007

Sonus Crashes On Failed Pivotal Trial Of Tocosol Paclitaxel Drug

Sep. 25, 2007

Sonus Crashes On Failed Pivotal Trial Of Tocosol Paclitaxel Drug

Sep. 25, 2007

View All Articles by Jim Shrine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 14, 2025.
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld Science
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld Science
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...